• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Therapeutic efficacy of combined application of lamivudine and bushen recipe in treating chronic hepatitis B and its influence on YMDD motif].

作者信息

Zhou Fei, Wang Ling-tai, Chen Jian-jie

机构信息

Affiliated Shuguang Hospital, Shanghai University of TCM, Shanghai 200021.

出版信息

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2003 Jun;23(6):417-20.

PMID:12872391
Abstract

OBJECTIVE

To observe the effect of combined application of Lamivudine and Bushen recipe (BSR) in treating patients with chronic hepatitis B (CHB) and its influence on tyrosine-methionine-aspartate-aspartate (YMDD) motif.

METHODS

Eighty-eight patients of CHB with positive HBV-DNA were divided into 3 groups, Group A treated with Lamivudine, Group B treated with Lamivudine plus BSR1 and Group C treated with Lamivudine plus BSR2, the serum HBV-DNA, hepatic biological parameters and YMDD motif mutation were observed.

RESULTS

The positive rate of HBV-DNA (6.45%) and YMDD motif mutation (3.23%) in Group C were lower than those in Group A respectively, after 52 weeks treatment.

CONCLUSION

Combined application of Lamivudine and BSR could enhance the therapeutic effect in treating CHB to certain extent, and could reduce the mutation of YMDD motif.

摘要

相似文献

1
[Therapeutic efficacy of combined application of lamivudine and bushen recipe in treating chronic hepatitis B and its influence on YMDD motif].
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2003 Jun;23(6):417-20.
2
Natural YMDD-motif mutants affect clinical course of lamivudine in chronic hepatitis B.天然YMDD基序突变体影响慢性乙型肝炎患者拉米夫定的临床病程。
World J Gastroenterol. 2015 Feb 21;21(7):2089-95. doi: 10.3748/wjg.v21.i7.2089.
3
[Influence of a triplex superimposed treatment on HBV replication and mutation during treating chronic hepatitis B].
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2001 Sep;15(3):236-8.
4
[A real-time PCR assay for the quantification of hepatitis B virus DNA and concurrent detection of YMDD motif mutations].一种用于定量乙型肝炎病毒DNA及同时检测YMDD基序突变的实时聚合酶链反应检测法
Mikrobiyol Bul. 2011 Oct;45(4):664-76.
5
[Effect of a Chinese herbal compound and lamivudine combination therapy on patients with chronic hepatitis B and its influence on YMDD motif mutation].
Zhonghua Gan Zang Bing Za Zhi. 2005 Dec;13(12):933, 936.
6
[Paying attention to TCM and integrative medicine in treating YMDD mutation of chronic hepatitis B].
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2008 Jan;28(1):9-10.
7
[Identification of factors associated with YMDD mutation in patients with chronic hepatitis B receiving lamivudine treatment].[拉米夫定治疗慢性乙型肝炎患者中与YMDD变异相关因素的识别]
Zhonghua Gan Zang Bing Za Zhi. 2009 Sep;17(9):641-4.
8
[Efficacy changes of short-term lamivudine therapy for chronic hepatitis B with emergence of YMDD mutation].[拉米夫定短期治疗慢性乙型肝炎出现YMDD变异后的疗效变化]
Zhonghua Gan Zang Bing Za Zhi. 2004 Jun;12(6):368-9.
9
YMDD motif mutations in chronic hepatitis B antiviral treatment naïve patients: a multi-center study.慢性乙型肝炎抗病毒治疗初治患者中 YMDD motif 突变:一项多中心研究。
Braz J Infect Dis. 2012 May-Jun;16(3):250-5.
10
[YMDD motif variants detected by Inno-Lipa HBV DR assay in chronic hepatitis B patients during lamivudine therapy].[拉米夫定治疗期间慢性乙型肝炎患者中通过Inno-Lipa HBV DR检测法检测到的YMDD基序变异]
Mikrobiyol Bul. 2008 Jul;42(3):445-50.

引用本文的文献

1
YMDD mutations in patients with chronic hepatitis B untreated with antiviral medicines.未接受抗病毒药物治疗的慢性乙型肝炎患者的YMDD突变
World J Gastroenterol. 2005 Feb 14;11(6):867-70. doi: 10.3748/wjg.v11.i6.867.